Adma Biologics Inc
ADMA
Market Cap$5.61B
Close$
$7.07
66.7% downside
Current Fair Value
66.7% downsideOvervalued by 66.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.61 Billion |
|---|---|
| Enterprise Value | $5.59 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.85 |
| Beta | 0.53 |
| Outstanding Shares | 236,433,759 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 28.13 |
|---|---|
| PEG | 2.16 |
| Price to Sales | 21.2 |
| Price to Book Ratio | 21.2 |
| Enterprise Value to Revenue | 14.6 |
| Enterprise Value to EBIT | 48.66 |
| Enterprise Value to Net Income | 82 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
ESG Score
No data